Literature DB >> 27436749

Magnitude and duration of cue-induced craving for marijuana in volunteers with cannabis use disorder.

Leslie H Lundahl1, Mark K Greenwald2.   

Abstract

AIMS: Evaluate magnitude and duration of subjective and physiologic responses to neutral and marijuana (MJ)-related cues in cannabis dependent volunteers.
METHODS: 33 volunteers (17 male) who met DSM-IV criteria for Cannabis Abuse or Dependence were exposed to neutral (first) then MJ-related visual, auditory, olfactory and tactile cues. Mood, drug craving and physiology were assessed at baseline, post-neutral, post-MJ and 15-min post MJ cue exposure to determine magnitude of cue- responses. For a subset of participants (n=15; 9 male), measures of craving and physiology were collected also at 30-, 90-, and 150-min post-MJ cue to examine duration of cue-effects.
RESULTS: In cue-response magnitude analyses, visual analog scale (VAS) items craving for, urge to use, and desire to smoke MJ, Total and Compulsivity subscale scores of the Marijuana Craving Questionnaire, anxiety ratings, and diastolic blood pressure (BP) were significantly elevated following MJ vs. neutral cue exposure. In cue-response duration analyses, desire and urge to use MJ remained significantly elevated at 30-, 90- and 150-min post MJ-cue exposure, relative to baseline and neutral cues.
CONCLUSIONS: Presentation of polysensory MJ cues increased MJ craving, anxiety and diastolic BP relative to baseline and neutral cues. MJ craving remained elevated up to 150-min after MJ cue presentation. This finding confirms that carry-over effects from drug cue presentation must be considered in cue reactivity studies.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Craving; Duration; Magnitude; Marijuana cue reactivity

Mesh:

Year:  2016        PMID: 27436749      PMCID: PMC5113710          DOI: 10.1016/j.drugalcdep.2016.07.004

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  49 in total

1.  Meta-analysis of cue-reactivity in addiction research.

Authors:  B L Carter; S T Tiffany
Journal:  Addiction       Date:  1999-03       Impact factor: 6.526

2.  Brief treatments for cannabis dependence: findings from a randomized multisite trial.

Authors: 
Journal:  J Consult Clin Psychol       Date:  2004-06

3.  Conditioning factors in drug abuse: can they explain compulsion?

Authors:  C P O'Brien; A R Childress; R Ehrman; S J Robbins
Journal:  J Psychopharmacol       Date:  1998       Impact factor: 4.153

4.  Cue-induced craving for marijuana in cannabis-dependent adults.

Authors:  Leslie H Lundahl; Chris-Ellyn Johanson
Journal:  Exp Clin Psychopharmacol       Date:  2011-06       Impact factor: 3.157

5.  Classically conditioned responses in opioid and cocaine dependence: a role in relapse?

Authors:  A R Childress; A T McLellan; R Ehrman; C P O'Brien
Journal:  NIDA Res Monogr       Date:  1988

6.  Cannabis withdrawal symptoms in non-treatment-seeking adult cannabis smokers.

Authors:  Kenneth H Levin; Marc L Copersino; Stephen J Heishman; Fang Liu; Deanna L Kelly; Douglas L Boggs; David A Gorelick
Journal:  Drug Alcohol Depend       Date:  2010-05-26       Impact factor: 4.492

7.  Cue reactivity in young marijuana smokers: a preliminary investigation.

Authors:  Kevin M Gray; Steven D LaRowe; Himanshu P Upadhyaya
Journal:  Psychol Addict Behav       Date:  2008-12

8.  Marijuana withdrawal and craving: influence of the cannabinoid receptor 1 (CNR1) and fatty acid amide hydrolase (FAAH) genes.

Authors:  Heather M Haughey; Erin Marshall; Joseph P Schacht; Ashleigh Louis; Kent E Hutchison
Journal:  Addiction       Date:  2008-08-14       Impact factor: 6.526

9.  Valproate treatment and cocaine cue reactivity in cocaine dependent individuals.

Authors:  Malcolm S Reid; Vatsal Thakkar
Journal:  Drug Alcohol Depend       Date:  2009-04-16       Impact factor: 4.492

10.  Effects of topiramate on cue-induced cigarette craving and the response to a smoked cigarette in briefly abstinent smokers.

Authors:  Malcolm S Reid; Joseph Palamar; Sumithra Raghavan; Frank Flammino
Journal:  Psychopharmacology (Berl)       Date:  2007-03-08       Impact factor: 4.415

View more
  6 in total

1.  Effects of exercise on experimentally manipulated craving for cannabis: A preliminary study.

Authors:  Sandy D Wilson; R Lorraine Collins; Mark A Prince; Paula C Vincent
Journal:  Exp Clin Psychopharmacol       Date:  2018-05-24       Impact factor: 3.157

2.  Cue-elicited increases in incentive salience for marijuana: Craving, demand, and attentional bias.

Authors:  Jane Metrik; Elizabeth R Aston; Christopher W Kahler; Damaris J Rohsenow; John E McGeary; Valerie S Knopik; James MacKillop
Journal:  Drug Alcohol Depend       Date:  2016-08-04       Impact factor: 4.492

3.  Approach bias modification for cannabis use disorder: A proof-of-principle study.

Authors:  Brian J Sherman; Nathaniel L Baker; Lindsay M Squeglia; Aimee L McRae-Clark
Journal:  J Subst Abuse Treat       Date:  2018-01-16

4.  Both active and sham low-frequency rTMS single sessions over the right DLPFC decrease cue-induced cravings among pathological gamblers seeking treatment: A randomized, double-blind, sham-controlled crossover trial.

Authors:  Anne Sauvaget; Samuel Bulteau; Alice Guilleux; Juliette Leboucher; Anne Pichot; Pierre Valrivière; Jean-Marie Vanelle; Véronique Sébille-Rivain; Marie Grall-Bronnec
Journal:  J Behav Addict       Date:  2018-02-21       Impact factor: 6.756

5.  The Association of Drug-Use Characteristics and Active Coping Styles With Positive Affect in Patients With Heroin-Use Disorder and Methamphetamine-Use Disorder During the COVID-19 Pandemic.

Authors:  Yingying Wang; Jinsong Zuo; Long Wang; Qianjin Wang; Xin Wang; Qian Yang; Hanjing Emily Wu; Colin B Goodman; Dongmei Wang; Tieqiao Liu; Xiangyang Zhang
Journal:  Front Public Health       Date:  2021-12-03

Review 6.  The importance of psychology for shaping legal cannabis regulation.

Authors:  Jacob T Borodovsky; Michael J Sofis; Richard A Grucza; Alan J Budney
Journal:  Exp Clin Psychopharmacol       Date:  2020-05-21       Impact factor: 3.157

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.